Kenyan insurer and healthcare service provider AAR Healthcare says it is tackling low uptake and fraud by allowing customers to pay for treatment and manage medical payments with their mobile through a new partnership with e-payment system M-TIBA.
HBI catches up with Abhishek Sharma, CEO of Foundation Holdings which is putting $125m towards building a primary care platform in the UAE. It has doubled its national footprint in the last 18 months and is targeting Saudi Arabia and the whole region next.
Indian for-profit super-speciality eyecare chain ASG has announced it has raised Rs 308 crore in a funding round led by global investment firm Foundation Holdings.
Seattle-based Columbia Pacific Management has agreed to sell Columbia Asia's Southeast Asia hospitals for $1.2bn cash and has kicked off a separate sale process for the Indian hospitals, sources familiar with the matter tell us. It is also planning to replicate its Asian success story in Africa, starting in Kenya, HBI can exclusively reveal.
Pan-Asian hospital group IHH Healthcare Berhad is further consolidating its strong position in Malaysia with the acquisition of a substantial private medical centre in its capital, Kuala Lumpur.
A large private hospital in the UAE closed this week, as a tougher payor climate because of the A-class expat exodus hits the sector, HBI is told. Another source says that some groups may have over-extended themselves trying to keep up with a dominant NMC Health.
A deal to buy pan-southeast Asian hospital group Columbia Asia has reportedly been agreed, while The Philippines' largest private hospital group's dual-track process is rolling on with a prospectus filed and second-round bids in.
Pan-African lab company Integrated Diagnostic Holdings (IDH) will soon start mining its database of 13m patients through a new subsidiary with the ultimate aim of layering extra services on top.
Brazilian health insurer Clinipam may be the target of four prospective buyers according to local reports – but the company denies it is for sale despite its apparent suitors. We speak to a Brazilian healthcare expert who tells us that Hapvida is the one to watch, and talk about its prospective targets and strategy.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.